TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Norwegian Pharma AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
10,862
|
11,396
|
15,872 |
Financial expenses |
42
|
51
|
117 |
Earnings before taxes |
2,022
|
2,368
|
4,862 |
Total assets |
6,880
|
9,056
|
13,377 |
Current assets |
6,880
|
9,056
|
13,377 |
Current liabilities |
1,810
|
1,558
|
1,725 |
Equity capital |
5,070
|
7,496
|
11,652 |
- share capital |
100
![]() |
100
![]() |
100 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
73.7%
|
82.8%
|
87.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
18.6%
|
20.8%
|
30.6% |
Return on assets (ROA) |
30.0%
|
26.7%
|
37.2% |
Current ratio |
380.1%
|
581.3%
|
775.5% |
Return on equity (ROE) |
39.9%
|
31.6%
|
41.7% |
Change turnover |
-534
|
-4,476
|
284 |
Change turnover % |
-5%
|
-28%
|
2% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.